HIGHLIGHTS
- who: Liuting Zeng from the University of Missouri, United States have published the paper: Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis, in the Journal: (JOURNAL) of 16/01/2022
- what: In this systematic review, only one RCT reported FMT for the treatment of systemic sclerosis and showed that at week 4, compared with one of two placebo controls, three patients in the experimental group reported a major improvement in fecal incontinence.
- how: 2) Duplicate literature research was conducted in the same . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.